Skip to content
Peptigraph home

Tirzepatide 30 mg Vial: Reconstitution and Dosing Chart

How much bacteriostatic water to add to a 30 mg vial of Tirzepatide, the concentration you get, and a full dose-to-units chart.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGLP-1 / GIP dual agonistUpdated
Vial size
30 mg
With 2 mL water
15 mg/mL
common choice
10 units contain
1.5 mg
at 2 mL, U-100
Whole vial
200 units
2 mL on a U-100 scale

How much water to add

Bacteriostatic water only changes the concentration, not the amount of Tirzepatide in the vial. More water means more units per dose (easier to read), less water means fewer.

Tirzepatide 30 mg vial: concentration by water added
Water addedConcentration10 units contain1 mg isWhole vial
1 mL30 mg/mL3 mg3.3 u100 u
2 mL15 mg/mL1.5 mg6.7 u200 u
2.5 mL12 mg/mL1.2 mg8.3 u250 u
3 mL10 mg/mL1 mg10 u300 u

Calculator and full dosing table

Preset to the 30 mg vial. Change any value; the table below the result updates with it.

1Vial size
2Bacteriostatic water added
3Dose per injection
4Syringe (U-100)
Draw to
33.33units
= 0.33 mL on a 1 mL U-100 insulin syringe
30 mg vial2 mL water5 mg dose
Concentration
15 mg/mL
Doses per vial
6
Weeks (1 dose/wk)
6
Math only. It does not recommend a dose.

33.33 units (0.33 mL) on a 1 mL U-100 syringe: 5 mg from a 30 mg vial + 2 mL water (Tirzepatide).

Dosing table for a 30 mg vial

Syringe units (U-100) for each dose, by how much bacteriostatic water you add.

Tirzepatide: U-100 syringe units per dose for a 30 mg vial
Dose1 mL water2 mL water2.5 mL water3 mL water
1 mg3.336.678.3310
2.5 mg8.3316.6720.8325
5 mg16.6733.3341.6750
7.5 mg255062.575
10 mg33.3366.6783.33100
12.5 mg41.6783.33104.17125
15 mg50100125150
20 mg66.67133.33166.67200

How the math works

Concentration is the vial's milligrams divided by the water you add. Volume to draw is your dose divided by that concentration. On a U-100 syringe, 1 mL is 100 units, so units = mL × 100.

30 mg ÷ 2 mL = 15 mg/mL
5 mg ÷ 15 mg/mL = 0.33 mL
0.33 mL × 100 = 33.33 units
33.33 units · 0.33 mL · 5 mg from 30 mg + 2 mL
Math only. The amounts in these tables are reference values for the arithmetic, not dose recommendations.

Where the doses behind the 30 mg vial maths come from

A 40-week open-label trial randomised 1879 patients to tirzepatide at 5 mg, 10 mg or 15 mg or to semaglutide at 1 mg.[3]

30 mg: weekly doses and syringe units

30 mg tirzepatide vial at 1 / 2 / 3 mL of water (30 / 15 / 10 mg/mL), per sourced dose, with doses per vial and units at 1 / 2 / 3 mL: 2.5 mg: 12 weekly doses, no remainder; 8.33 / 16.67 / 25 units. 5 mg: 6 weekly doses, no remainder; 16.67 / 33.33 / 50 units. 10 mg: 3 weekly doses, no remainder; 33.33 / 66.67 / 100 units. 15 mg: 2 weekly doses, no remainder; 50 / 100 / 150‡ units. († marks a 30 mg tirzepatide reading under 5 units, hard to measure accurately; ‡ marks one over the 100 units a 1 mL U-100 syringe holds.)

Calculated from vial mg 30; water mL 1, 2, 3; units per mL 100; doses mg 2.5, 5, 10, 15; rows dose mg 2.5, doses 12, remainder mg 0, units 8.333, 16.667, 25; dose mg 5, doses 6, remainder mg 0, units 16.667, 33.333, 50; dose mg 10, doses 3, remainder mg 0, units 33.333, 66.667, 100; dose mg 15, doses 2, remainder mg 0, units 50, 100, 150. Formula: doses = floor(vialMg / doseMg); units = doseMg x waterMl / vialMg x 100

Measuring check for the 30 mg vial: 1 mL (30 mg/mL) spans 8.33 to 50 units, all within 5 to 100; 2 mL (15 mg/mL) spans 16.67 to 100 units, all within 5 to 100; 3 mL (10 mg/mL) spans 25 to 150 units, some over 100 units. For tirzepatide at 30 mg, every sourced dose is readable between 5 and 100 units at 1 mL and 2 mL.

Calculated from vial mg 30; doses mg 2.5, 5, 10, 15; readable range units 5, 100. Formula: units = doseMg x waterMl / vialMg x 100, checked against 5 and 100

Is 30 mg a labelled tirzepatide strength?

Zepbound's label lists a multi-dose vial at 30 mg/2.4 mL (12.5 mg/mL), with a 0.6 mL dose volume.[4]

Dissolving 30 mg in 2.4 mL gives 12.5 mg/mL against the labelled 12.5 mg/mL, and the labelled 7.5 mg dose is a 0.6 mL draw, which is 60 units on a U-100 syringe.

Calculated from vial mg 30; label total mL 2.4; label dose mL 0.6; label dose mg 7.5; label conc mg per mL 12.5; units per mL 100. Formula: 30 / 2.4 = 12.5 mg/mL; 0.6 mL x 100 = 60 units

Listed price for 30 mg

The price dataset has 30 single-vial listings at 30 mg with a median of $180.00, which works out to $6.00 per mg; listings ranged from $85.00 to $400.00 when checked on 2026-10-02.

Calculated from source our price listings dataset; vial mg 30; listings 30; median 180; min 85; max 400; checked 2026-10-02. Formula: median / vialMg = 180.0 / 30 = 6.00 per mg

Common questions

How much water goes in a 30 mg vial of Tirzepatide?

That choice only changes the concentration. With 2 mL, a 30 mg vial is 15 mg/mL; with 1 mL it is 30 mg/mL. Less water means fewer units per dose and harder-to-read marks for small doses.

How many units is 1 mg from a 30 mg vial?

With 2 mL of water, 1 mg is 6.7 units on a U-100 syringe. With other water amounts, see the table.

How many doses are in a 30 mg vial?

Divide the vial size by the dose (in the same unit). The calculator on this page shows the number of whole doses for any dose you pick.

How much water goes in a 30mg tirzepatide vial?

The water volume only sets the strength: 30 mg of tirzepatide in 1, 2 or 3 mL is 30, 15 or 10 mg/mL, which is 300, 150 or 100 mcg per syringe unit.

Calculated from vial mg 30; water mL 1, 2, 3; units per mL 100. Formula: mg/mL = 30 / mL; mg per unit = (mg/mL) / 100

What is the tirzepatide 30mg dosage?

Dose changes on the Zepbound label are 2.5 mg apart and need at least 4 weeks at the current dose.[4]

More on Tirzepatide

Sources

  1. 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
  2. 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
  3. 3Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.The New England journal of medicine · 2021PMID 34170647Accessed 2 Oct 2026
  4. 4ZEPBOUND prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026

Found an error? Report a correction.